Clinical trial

Efficacy and Safety of Camrelizumab in Real-World Prospective Study

NCT04793139

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-04-01

PhaseN/A

Study timeline

Study start (estimated)2021-04-01Date precision: day

Registry last updated2021-03-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

CamrelizumabDRUG

Sponsors & collaborators

Guangdong Association of Clinical Trialslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04793139 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.